{"id":"W2902348306","doi":"10.1111/ajco.13059","title":"Prime time for immunotherapy in advanced urothelial cancer","year":2018,"lang":"en","type":"review","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Carboplatin; Oncology; Internal medicine; Clinical trial; Chemotherapy; Disease; Cisplatin; Immunotherapy; Cancer; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003179641,0.0003079297,0.0006466312,0.001342499,0.0003415227,0.002079903,0.0006010643,0.001264718,0.02389831],"category_scores_gemma":[0.0046966,0.0001209949,0.0008812765,0.001498083,0.0003574501,0.002425616,0.0009420943,0.001794259,0.002964642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006739801,"about_ca_system_score_gemma":0.002064605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002298943,"about_ca_topic_score_gemma":0.0006724368,"domain_scores_codex":[0.9986438,0.0006253177,0.0001638409,0.0001172637,0.0003785,0.00007136005],"domain_scores_gemma":[0.9965988,0.001808152,0.0007701319,0.0000912859,0.0004477999,0.0002839952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004286381,0.00008702915,0.0013194,0.04766852,0.0002534907,0.0002496117,0.0002024608,0.0001669366,0.001501379,0.008834745,0.1539141,0.7853737],"study_design_scores_gemma":[0.00008869521,0.0002584056,0.001450841,0.01576747,0.0002667298,0.0006746485,0.000166145,0.00006031519,0.0003937157,0.004144611,0.9767181,0.00001027919],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001456719,0.9624207,0.000762861,0.01833127,0.004497819,0.00008637801,0.0005594584,0.00003748847,0.01184725],"genre_scores_gemma":[0.03007763,0.9289733,0.003196895,0.01984551,0.008397777,0.0002516774,0.001326125,0.00004629398,0.007884765],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02389831,"threshold_uncertainty_score":0.07994777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1308510256706974,"score_gpt":0.5175727264392097,"score_spread":0.3867217007685123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}